DK0667872T3 - Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6 - Google Patents

Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6

Info

Publication number
DK0667872T3
DK0667872T3 DK94900984T DK94900984T DK0667872T3 DK 0667872 T3 DK0667872 T3 DK 0667872T3 DK 94900984 T DK94900984 T DK 94900984T DK 94900984 T DK94900984 T DK 94900984T DK 0667872 T3 DK0667872 T3 DK 0667872T3
Authority
DK
Denmark
Prior art keywords
interleukin
biological activity
mutant
type
activity over
Prior art date
Application number
DK94900984T
Other languages
Danish (da)
English (en)
Inventor
Gennaro Ciliberto
Rocco Savino
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Application granted granted Critical
Publication of DK0667872T3 publication Critical patent/DK0667872T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5412IL-6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • Y10S930/141Interleukin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides
    • Y10S930/142Interferon

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK94900984T 1992-11-06 1993-11-02 Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6 DK0667872T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM920809A IT1263022B (it) 1992-11-06 1992-11-06 Interleuchina-6 mutante con attivita' biologica migliorata rispetto all'interleuchina-6 selvatica.
PCT/IT1993/000114 WO1994011402A1 (en) 1992-11-06 1993-11-02 Mutant interleukin 6 with improved biological activity over wild interleukin 6

Publications (1)

Publication Number Publication Date
DK0667872T3 true DK0667872T3 (da) 2000-09-18

Family

ID=11401276

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94900984T DK0667872T3 (da) 1992-11-06 1993-11-02 Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6

Country Status (12)

Country Link
US (1) US5681723A (ja)
EP (1) EP0667872B1 (ja)
JP (1) JP2515491B2 (ja)
AT (1) ATE191923T1 (ja)
CA (1) CA2129824C (ja)
DE (1) DE69328437T2 (ja)
DK (1) DK0667872T3 (ja)
ES (1) ES2145819T3 (ja)
GR (1) GR3033685T3 (ja)
IT (1) IT1263022B (ja)
PT (1) PT667872E (ja)
WO (1) WO1994011402A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274782B (it) * 1994-12-14 1997-07-24 Angeletti P Ist Richerche Bio Metodo per selezionare superagonisti, antagonisti e superantagonisti di ormoni del cui complesso recettoriale fa parte gp 130
IT1277926B1 (it) * 1995-09-01 1997-11-12 Angeletti P Ist Richerche Bio Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
AU6961796A (en) * 1995-09-12 1997-04-01 Chiron Corporation Improved interleukin-6 receptor antagonist
AU7078200A (en) 1999-08-27 2001-03-26 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Polypeptides, comprising il-6 ligand-binding receptor domains and related nucleic acids, antibodies, compositions, and methods of use
IL161673A0 (en) 2004-04-29 2004-09-27 Applied Research Systems Compositions and methods for therapy of chemotherapy-induced neuropathy
JP6280031B2 (ja) 2012-03-29 2018-02-14 中外製薬株式会社 抗lamp5抗体およびその利用
US20240269236A1 (en) 2021-06-04 2024-08-15 Sonnet BioTherapeutics, Inc. Methods of treating age-related frailty with interleukin-6

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT52962A (en) * 1988-03-04 1990-09-28 Sandoz Ag Process for production of medical compositions eliminating bone-absorption and promoting forming of bones
US5210075A (en) * 1990-02-16 1993-05-11 Tanabe Seiyaku Co., Ltd. Interleukin 6 antagonist peptides

Also Published As

Publication number Publication date
US5681723A (en) 1997-10-28
CA2129824C (en) 1997-03-04
EP0667872A1 (en) 1995-08-23
DE69328437D1 (de) 2000-05-25
IT1263022B (it) 1996-07-23
WO1994011402A1 (en) 1994-05-26
JPH07501947A (ja) 1995-03-02
GR3033685T3 (en) 2000-10-31
ITRM920809A1 (it) 1994-05-06
JP2515491B2 (ja) 1996-07-10
PT667872E (pt) 2000-08-31
ITRM920809A0 (it) 1992-11-06
DE69328437T2 (de) 2000-11-02
CA2129824A1 (en) 1994-05-26
ATE191923T1 (de) 2000-05-15
ES2145819T3 (es) 2000-07-16
EP0667872B1 (en) 2000-04-19

Similar Documents

Publication Publication Date Title
ES2162132T3 (es) Polimerasa de adn termoestable procedente de thermoanaerobacter thermohydrosulfuricus y enzimas mutantes, de actividad exonucleasa suprimida asi obtenidos.
DE69435049D1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
DE69635452D1 (de) Hohe expressionsrate des grün-fluoreszierenden proteins
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
ATE335078T1 (de) Überexpression von säugetier- und virusproteinen
DE69534875D1 (de) Kalziumfreie subtilisin mutanten
PT1118619E (pt) Metodo para identificar agentes activos contra o vhc utilizando as coordenadas estruturais da protease do virus da hepatite c
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
DK0667872T3 (da) Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6
DE69229862D1 (de) Cysteinfreie il-6 mutanten
ES2058479T3 (es) Compuestos peptidicos.
ES2168282T3 (es) D-hidantoinasa recombinante, procedimiento para su preparacion y utilizacion.
ES8900018A1 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos inhibidores de la renina y de las proteasas acidas
DE69531673D1 (de) Tcf mutante
DK0713365T4 (da) Rugmel
MY104405A (en) Structural gene comprising dna coding for an endotoxin protein having toxic activity against insects.
ATE103979T1 (de) Menschliches lymphotoxin.
KR920703636A (ko) 온코스타틴 m 활성을 가진 신규한 단백질과 그 제조과정
DE3854195D1 (de) Polypeptid-verbindungen.
ATE266096T1 (de) Mutant des inhibitors des erythrina caffra typs und dessen verwendung zur reinigung von serinproteasen
DE60015067D1 (de) Enzym mit Xylanaseaktivität
SE9604439D0 (sv) New receptor
Paberit et al. Isolation and properties of neutral metalloprotease from thermophilic bacteria Bacillus brevis.
EP0386240A4 (en) Novel polypeptide compounds
JPS6474986A (en) Protease and a novel microorganism producing the same